External Validation of a Survival Nomogram for Non-Small Cell Lung Cancer Using the National Cancer Database

Area of Science:

• Oncology
• Biostatistics
• Cancer Research

Background:

• Survival nomograms offer personalized predictions beyond traditional staging systems like the AJCC TNM.
• A previously developed nomogram for overall survival (OS) in resected, non-metastatic NSCLC was based on Asian patient data.

Purpose of the Study:

• To assess the predictive accuracy of an existing NSCLC survival nomogram in a US patient population.
• To compare the nomogram's performance against the established AJCC TNM Staging System using the National Cancer Database (NCDB).

Main Methods:

• Retrospective analysis of 57,313 adult patients with resected, non-metastatic NSCLC from the NCDB (2004-2012).
• Evaluation of nomogram and AJCC TNM discrimination and calibration using concordance indices and calibration plots.
• Multivariate analysis was employed to further assess predictive factors.

Main Results:

• The nomogram achieved a concordance index (C-index) of 0.804, indicating good predictive discrimination.
• AJCC TNM staging demonstrated a higher C-index of 0.833, suggesting superior discriminatory power.
• The study included diverse NSCLC histologies and stages, with a median OS of 74 months.

Conclusions:

• The survival nomogram accurately predicted outcomes in the US cohort, outperforming its original developer's cohorts.
• Despite the nomogram's utility for individualized predictions, AJCC TNM staging provides superior generalized prognostic capability.
• AJCC TNM staging should continue as the gold standard for prognostication in resected NSCLC within the US.